Press Releases for CRIS

Press Releases
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
Curis Reports Second Quarter 2009 Financial Results and Provides Pipeline Update
Curis to Release Second Quarter 2009 Financial Results and Hold Conference Call on July 30, 2009
Curis Added to Russell 3000® and Russell 2000® Indexes
Curis Announces Issuance of U.S. Patent Covering CUDC-101 Composition of Matter for Novel HDAC/EGFR/Her2 Inhibitor
Curis Publishes Preclinical Data for Heat Shock Protein 90 Molecule CUDC-305 in Clinical Cancer Research
Curis to Present at the 8th Annual Needham Life Sciences Conference
Curis to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
Curis Reports First Quarter 2009 Financial Results
Curis to Release First Quarter 2009 Financial Results and Hold Conference Call on May 5, 2009
Curis Presents Preclinical Data for CU-903 at Keystone Symposia Event “PI3 Kinase Signaling in Disease”
Curis Presents CUDC-305 Preclinical Data at the AACR 100th Annual Meeting 2009
Curis Announces Presentations at American Association for Cancer Research Annual Meeting 2009
Curis to Present at the Cowen and Company 29th Annual Health Care Conference
Curis to Present at the Barclays Capital Global Healthcare Conference
Curis Announces Genentech’s Initiation of Pivotal Phase II Trial of GDC-0449 in Advanced Basal Cell Carcinoma
Curis Reports Fourth Quarter and Year-End 2008 Financial Results
Curis to Present at the 11th Annual BIO CEO Investor Conference
Curis to Release Fourth Quarter and Year-end 2008 Financial Results and Hold Conference Call on February 10, 2009
Curis Announces Genentech’s Expected Initiation of Pivotal Phase II Trial in Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitor
Curis Announces Genentech’s Initiation of Phase II Clinical Trial in Advanced Ovarian Cancer with Hedgehog Pathway Inhibitor
Curis to Present at RBC Capital Markets 2008 Healthcare Conference
Curis to Present at Lazard Capital Markets 5th Annual Healthcare Conference
Curis Announces Collaborator Genentech's License of Ex-U.S. Rights to GDC-0449 to Roche
Curis to Present at 10th Annual Rodman & Renshaw Healthcare Conference
Curis Reports Third Quarter 2008 Financial Results
Curis to Present at 19th Annual Oppenheimer Healthcare Conference
Curis Announces Preclinical Efficacy Data for CUDC-305 at EORTC-NCI-AACR Symposium
Curis to Present at 7th Annual BIO Investor Forum Conference
Curis to Release Third Quarter 2008 Financial Results and Hold Conference Call on October 28, 2008
Curis to Present at First Annual Boston Biotech R&D Conference
Curis to Present at Maxim Group Growth Conference 2008
Curis to Present at Merriman Curhan Ford 5th Annual Investor Summit 2008
Curis Announces GDC-0449 Phase II Ovarian Cancer Trial Design
Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors
Curis Announces Dosing of First Patient in Phase I Clinical Trial of CUDC-101
Curis to Present at Noble Financial Capital Markets 5th Annual Equity Conference
Curis Reports Second Quarter 2008 Financial Results
Curis to Release Second Quarter 2008 Financial Results and Hold Conference Call on July 30, 2008
Curis Selects Hsp90 Inhibitor CUDC-305 as Development Candidate from Targeted Cancer Drug Development Platform
Curis Announces GDC-0449 Phase I Clinical Data Presented at American Society of Clinical Oncology Annual Meeting 2008
Curis to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference - Jun 1 2008 4:54PM
New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC - May 27 2008 1:18AM
Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer - Jun 1 2008 4:53PM
Curis Reports First Quarter 2008 Financial Results
Curis to Present at Deutsche Bank 33rd Annual Healthcare Conference
Curis to Release First Quarter 2008 Financial Results and Hold Conference Call on April 30, 2008
Curis Announces GDC-0449 Phase I Clinical Data Presented at AACR Annual Meeting 2008
Curis Announces Preclinical Efficacy Data for CUDC-101 at AACR Annual Meeting 2008
Curis announces presentations at American Association for Cancer Research Annual Meeting 2008
Curis Announces Presentation at the 235th American Chemical Society National Meeting